Aptevo Therapeutics Inc. Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount
Aptevo Therapeutics Inc. (APVO) reported Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount of $5.10 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-26.
Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets
us-gaap:ValuationAllowanceDeferredTaxAssetChangeInAmount · last filed 2026-03-26
- Aptevo Therapeutics Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2025 was $5.10M.
- Aptevo Therapeutics Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2024 was -$4.00M, a 195.24% decline from fiscal 2023.
- Aptevo Therapeutics Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2023 was $4.20M.
- Aptevo Therapeutics Inc. valuation allowance, deferred tax asset, increase (decrease), amount for fiscal 2022 was -$1.10M, a 118.33% decline from fiscal 2021.
| Period end | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount 12 month |
|---|---|
| 2025-12-31 | $5.10M 10-K · filed 2026-03-26 |
| 2024-12-31 | -$4.00M 10-K · filed 2025-02-14 |
| 2023-12-31 | $4.20M 10-K · filed 2024-03-05 |
| 2022-12-31 | -$1.10M 10-K · filed 2023-03-30 |
| 2021-12-31 | $6.00M 10-K · filed 2022-03-24 |
| 2016-12-31 | -$83.30M 10-K · filed 2017-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Onconetix, Inc. (ONCO) | United States | $0.004B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| HCW Biologics Inc. (HCWB) | United States | $0.004B | -6.15 |
| REVELATION BIOSCIENCES, INC. (REVB) | United States | $0.004B | |
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Genprex, Inc. (GNPX) | United States | $0.003B | -0.02 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B |